Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hüttl

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Der Anaesthesist|February 11, 2017
[Learning how to learn for specialist further education]G Breuer, B Lütcke, M St Pierre, et al.
Clinical Cardiology|June 1, 1995
Beneficial clinical effect of very early enalapril treatment in patients with acute left ventricular failure complicating myocardial infarctionS Hüttl, J Nussberger, K Lehmann, et al.
Virchows Archiv : an International Journal of Pathology|March 3, 2021
The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOSKatrin S Hüttl, Annette M Staiger, Julia Richter, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Der Anaesthesist|February 11, 2017
[Learning how to learn for specialist further education]G Breuer, B Lütcke, M St Pierre, et al.
Clinical Cardiology|June 1, 1995
Beneficial clinical effect of very early enalapril treatment in patients with acute left ventricular failure complicating myocardial infarctionS Hüttl, J Nussberger, K Lehmann, et al.
Virchows Archiv : an International Journal of Pathology|March 3, 2021
The "Burkitt-like" immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOSKatrin S Hüttl, Annette M Staiger, Julia Richter, et al.
Leukemia|September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHLAnnette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Pageof 1